A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancer
2003 ◽
Vol 52
(4)
◽
pp. 339-345
◽
Keyword(s):
Phase Ii
◽
2013 ◽
Vol 72
(5)
◽
pp. 1097-1102
◽
2007 ◽
Vol 96
(3)
◽
pp. 439-444
◽